Forrest Capital / Howard Digby / Peter Webse have been involved in moving assets into other ASX companies, such as OSL (Cancer) and CYP (Stem Cell). Both now very much alive companies (check out the charts). Hopefully something similarly innovative / forward-thinking will be moved into SBN, and hopefully part of the $1m+ cash balance can be used as consideration, with a cap raise done at higher prices, supported by the major holders. Just patience needed with the current board imo. Company has been looking for acquisitions for a while, but less than a year with the current board. What's in it for them? Well, adviser shares/options were part of the OSL deal.
SBN Price at posting:
0.7¢ Sentiment: None Disclosure: Held